| 創建日期 | 上櫃日期 | 董事長 | 總經理 |
|---|---|---|---|
| 69/08/22 | 102/09/12 | 林詠翔 | 林詠翔 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| 1.8(Q2) | 20.19 | 2.62 | 2.89% |
| 實收資本額 | 已發行普通股 | ||
| 1,182,608,300 | 118,260,830 | ||
| 主要經營業務 | |||
| 保健食品及保養品之研發、製造及銷售 | |||
| 公司網址 | |||
| tci-bio.com | |||
大江(8436) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 781,469 | 715,953 | 11.7% | 9.1% | 5,323,159 | 4,862,259 | 9.5% |
| 2023/07 | 699,750 | 637,598 | 1.1% | 9.7% | 4,541,690 | 4,146,306 | 9.5% |
| 2023/06 | 692,009 | 649,221 | 4.2% | 6.6% | 3,841,940 | 3,508,708 | 9.5% |
| 2023/05 | 663,820 | 630,766 | 8.2% | 5.2% | 3,149,931 | 2,859,487 | 10.1% |
| 2023/04 | 613,254 | 570,736 | -5.6% | 7.4% | 2,486,111 | 2,228,721 | 11.5% |
| 2023/03 | 649,936 | 549,459 | 15.8% | 18.3% | 1,872,857 | 1,657,985 | 12.9% |
| 2023/02 | 561,018 | 484,585 | -15.2% | 15.8% | 1,222,921 | 1,108,526 | 10.3% |
| 2023/01 | 661,903 | 623,941 | 9.6% | 6.1% | 661,903 | 623,941 | 6.1% |
| 2022/12 | 603,802 | 640,672 | -5.7% | -5.8% | 7,432,514 | 8,579,112 | -13.4% |
| 2022/11 | 640,546 | 634,966 | 3.5% | 0.9% | 6,828,712 | 7,938,440 | -14% |
| 2022/10 | 619,129 | 639,649 | -12.4% | -3.2% | 6,188,166 | 7,303,474 | -15.3% |
| 2022/09 | 706,778 | 701,783 | -1.3% | 0.7% | 5,569,037 | 6,663,825 | -16.4% |
| 2022/08 | 715,953 | 839,908 | 12.3% | -14.8% | 4,862,259 | 5,962,042 | -18.4% |
| 2022/07 | 637,598 | 835,725 | -1.8% | -23.7% | 4,146,306 | 5,122,134 | -19% |
| 2022/06 | 649,221 | 807,034 | 2.9% | -19.5% | 3,508,708 | 4,286,409 | -18.1% |
| 2022/05 | 629,151 | 732,648 | 10.2% | -14.1% | 2,857,872 | 3,479,375 | -17.9% |
| 2022/04 | 570,736 | 800,797 | 3.9% | -28.7% | 2,228,721 | 2,746,727 | -18.9% |
| 2022/03 | 549,459 | 809,383 | 13.4% | -32.1% | 1,657,985 | 1,945,930 | -14.8% |
| 2022/02 | 484,585 | 523,017 | -22.3% | -7.3% | 1,108,526 | 1,136,547 | -2.5% |
| 2022/01 | 623,941 | 613,530 | -2.6% | 1.7% | 623,941 | 613,530 | 1.7% |
| 2021/12 | 640,672 | 737,131 | 0.9% | -13.1% | 8,579,112 | 8,223,851 | 4.3% |
| 2021/11 | 634,966 | 686,734 | -0.7% | -7.5% | 7,938,440 | 7,486,720 | 6% |
| 2021/10 | 639,649 | 631,006 | -8.9% | 1.4% | 7,303,474 | 6,799,986 | 7.4% |
| 2021/09 | 701,783 | 644,154 | -16.4% | 8.9% | 6,663,825 | 6,168,980 | 8% |
| 2021/08 | 839,908 | 760,499 | 0.5% | 10.4% | 5,962,042 | 5,524,826 | 7.9% |
| 2021/07 | 835,725 | 752,079 | 3.5% | 11.1% | 5,122,134 | 4,764,327 | 7.5% |
| 2021/06 | 807,034 | 746,753 | 10.1% | 8.1% | 4,286,409 | 4,012,248 | 6.8% |
| 2021/05 | 732,648 | 726,383 | -8.5% | 0.9% | 3,479,375 | 3,265,495 | 6.5% |
| 2021/04 | 800,797 | 733,948 | -1.1% | 9.1% | 2,746,727 | 2,539,112 | 8.2% |
| 2021/03 | 809,383 | 723,600 | 54.8% | 11.9% | 1,945,930 | 1,805,164 | 7.8% |
| 2021/02 | 523,017 | 569,830 | -14.8% | -8.2% | 1,136,547 | 1,081,564 | 5.1% |
| 2021/01 | 613,530 | 511,734 | -16.8% | 19.9% | 613,530 | 511,734 | 19.9% |
| 2020/12 | 737,131 | 813,105 | 7.3% | -9.3% | 8,223,851 | 9,566,132 | -14% |
| 2020/11 | 686,734 | 797,028 | 8.8% | -13.8% | 7,486,720 | 8,753,027 | -14.5% |
| 2020/10 | 631,006 | 719,276 | -2% | -12.3% | 6,799,986 | 7,955,999 | -14.5% |
| 2020/09 | 644,154 | 637,130 | -15.3% | 1.1% | 6,168,980 | 7,236,723 | -14.8% |
大江(8436) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 5.14% | 1.57% | 2020Q3 | -2.28% | 1.02% |
| 2023Q1 | 0.50% | 2.89% | 2020Q2 | 22.27% | -4.26% |
| 2022Q4 | -9.55% | -0.69% | 2020Q1 | -22.51% | -8.14% |
| 2022Q3 | 11.42% | -4.07% | 2019Q4 | 12.48% | -4.62% |
| 2022Q2 | 11.53% | -5.93% | 2019Q3 | -19.79% | -3.21% |
| 2022Q1 | -13.43% | -3.36% | 2019Q2 | -0.09% | 10.16% |
| 2021Q4 | -19.44% | -1.60% | 2019Q1 | -7.47% | 16.16% |
| 2021Q3 | 1.58% | 2.60% | 2018Q4 | 16.16% | 24.79% |
| 2021Q2 | 20.28% | 1.59% | 2018Q3 | 47.82% | 24.24% |
| 2021Q1 | -5.30% | 1.71% | 2018Q2 | 27.52% | 15.53% |
| 2020Q4 | -4.72% | -3.23% | 2018Q1 | 7.75% | 10.62% |
評論0